Literature DB >> 19422444

Recollections on the discovery of factor VIIa as a novel therapeutic agent for hemophiliacs with inhibitors.

W Kisiel1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19422444     DOI: 10.1111/j.1538-7836.2009.03450.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  2 in total

Review 1.  Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients.

Authors:  John Puetz
Journal:  Drug Des Devel Ther       Date:  2010-07-21       Impact factor: 4.162

Review 2.  Recombinant activated factor VII in clinical practice: a 2014 update.

Authors:  Massimo Franchini; Silvia Crestani; Francesco Frattini; Cinzia Sissa; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2015-02       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.